Overview

Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children

Status:
Completed

Trial end date:
2020-06-20

Target enrollment:

Participant gender:

Summary

This randomized, double-blind, placebo-controlled phase 2 trial will be conducted at a single tertiary pediatric intensive care unit (PICU). The study will include children with RSV infection who were admitted to the pediatric intensive care unit and require respiratory support via positive pressure ventilation (invasive and noninvasive).

Phase:

Phase 2

Details

Lead Sponsor:

University of Alabama at Birmingham

Treatments:

Azithromycin